非居家出院的重症患者衰弱与长期生存:一项回顾性队列研究
这项回顾性多中心队列研究纳入2018年1月1日至2022年3月31日澳大利亚和新西兰ICU收治的、有临床衰弱量表(CFS)记录且非居家出院的成年内科患者57,652例,其中衰弱(CFS 5-8)17,383例(30.2%)。主要终点为最长4年生存时间。衰弱患者4年生存率低于非衰弱患者(32.5% vs 64.3%;p<0.001),衰弱与更短生存时间独立相关(aHR 1.50;95%CI 1.43-1.57)。亚组分析显示,年龄<65岁者aHR 1.73(95%CI 1.59-1.88),65-80岁者aHR 1.47(95%CI 1.38-1.57),>80岁者aHR 1.35(95%CI 1.26-1.45);出院至康复机构者aHR 1.52(95%CI 1.39-1.65),出院至急性医院者aHR 1.56(95%CI 1.48-1.65),出院至养老院者aHR 0.94(95%CI 0.83-1.06)。
要点
- 在ICU非居家出院的内科患者中,衰弱(CFS 5-8)者占30.2%(17,383/57,652),4年生存率32.5% vs 非衰弱者64.3%(p<0.001)。
- 衰弱与更短生存时间独立相关:aHR 1.50(95%CI 1.43-1.57)。
- 年龄<65岁者衰弱相关生存缩短更明显(aHR 1.73;95%CI 1.59-1.88),65-80岁aHR 1.47(95%CI 1.38-1.57),>80岁aHR 1.35(95%CI 1.26-1.45)。
- 出院至康复机构者aHR 1.52(95%CI 1.39-1.65),出院至急性医院者aHR 1.56(95%CI 1.48-1.65),出院至养老院者aHR 0.94(95%CI 0.83-1.06)。
- 作者结论:衰弱与非居家出院后更短生存时间独立相关。
适用人群与场景
- 2018年1月1日至2022年3月31日入住澳大利亚和新西兰ICU、有临床衰弱量表(CFS)记录且非居家出院的成年内科患者(≥16岁)。
诊断标准与关键阈值
- 衰弱定义为临床衰弱量表(CFS)评分5-8分。
- 非居家出院定义为出院至康复机构或养老院(RACF)。
研究设计与关键结果
- 研究类型:回顾性多中心队列研究;样本量57,652例,其中衰弱17,383例(30.2%)。
- 主要终点为最长4年生存时间;衰弱患者4年生存率32.5% vs 非衰弱患者64.3%(p<0.001)。
- 衰弱与更短生存时间独立相关:aHR 1.50(95%CI 1.43-1.57)。
- 年龄<65岁者aHR 1.73(95%CI 1.59-1.88),65-80岁者aHR 1.47(95%CI 1.38-1.57),>80岁者aHR 1.35(95%CI 1.26-1.45)。
- 出院至康复机构者aHR 1.52(95%CI 1.39-1.65),出院至急性医院者aHR 1.56(95%CI 1.48-1.65),出院至养老院(RACF)者aHR 0.94(95%CI 0.83-1.06)。
证据类型、等级与局限
- 证据类型:回顾性多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对ICU非居家出院患者,临床衰弱量表(CFS)评分5-8分提示长期生存时间更短,尤其年龄<65岁者aHR 1.73(95%CI 1.59-1.88),可据此在出院规划与随访中识别高风险人群。
- 出院至康复机构或急性医院者衰弱相关生存缩短更明显(aHR 1.52,95%CI 1.39-1.65;aHR 1.56,95%CI 1.48-1.65),出院至养老院者未达统计学显著(aHR 0.94;95%CI 0.83-1.06)。
- 作者结论:衰弱与非居家出院后更短生存时间独立相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Patients with frailty are more frequently discharged to rehabilitation or residential aged care facility (RACF), defined as nonhome discharge, than those without frailty. An increase in nonhome discharge is considered to be one of the collateral "costs" associated with declining hospital mortality. However, it is unclear whether this association applies to patients with frailty, particularly in the long term.
OBJECTIVES: To determine the impact of frailty on long-term survival in patients who had a nonhome discharge following an ICU admission.
DESIGN: A retrospective multicenter cohort study.
SETTING AND PARTICIPANTS: All medical patients (≥ 16 yr old) admitted to Australian and Zealand ICUs, with a documented Clinical Frailty Scale (CFS) and a nonhome discharge from January 1, 2018, to March 31, 2022, were included.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Primary outcome was survival time up to 4 years. We used Cox proportional hazards regression models with robust sandwich variance estimators to assess the effect of frailty (defined as CFS = 5-8) on survival time after ICU admission between groups. We also analyzed the effect of frailty on long-term survival based on their age and nonhome discharge location. Of the 57,652 patients, 17,383 (30.2%) were frail. Overall 4-year survival was lower in patients with frailty than those without (32.5% vs. 64.3%; p < 0.001). Frailty was associated with shorter survival times (adjusted hazard ratio [aHR], 1.50; 95% CI, 1.43-1.57). Frailty was associated with a greater reduction in survival in patients younger than 65 years old (aHR, 1.73; 95% CI, 1.59-1.88), 65-80 years (aHR, 1.47; 95% CI, 1.38-1.57), or older than 80 years (aHR, 1.35; 95% CI, 1.26-1.45). Frailty was associated with greater reduction in survival in those discharged to rehabilitation (aHR, 1.52; 95% CI, 1.39-1.65) or acute hospitals (aHR, 1.56; 95% CI, 1.48-1.65) than those discharged to RACF (aHR, 0.94; 95% CI, 0.83-1.06).
CONCLUSIONS: Frailty was independently associated with shorter time to death following a nonhome discharge after an ICU admission.
RELEVANCE: There was an independent association between patients with frailty admitted to ICU and had a nonhome discharge with the shorter time to death than those without frailty.
参考来源
- Mehta H, Ling RR, Ramanan M, et al. Frailty and Long-Term Survival in Patients With Critical Illness After Nonhome Discharge: A Retrospective Cohort Study. Crit Care Med. 2025. PMID: 40298485. doi:10.1097/CCM.0000000000006684
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。